Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
84.380,20
0,50%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Veracyte Inc (VCYT) Veracyte Inc (VCYT) Notizie

VCYT

Veracyte (VCYT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VCYT
DataOraFonteTitoloSimboloCompagnia
10/03/202521:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
07/03/202522:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCYTVeracyte Inc
28/02/202503:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCYTVeracyte Inc
24/02/202522:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
24/02/202522:05Business WireVeracyte Announces Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
19/02/202523:05Business WireVeracyte to Participate in Upcoming Investor ConferencesNASDAQ:VCYTVeracyte Inc
14/02/202514:30Business WireNew Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer ResearchNASDAQ:VCYTVeracyte Inc
12/02/202512:01Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VCYTVeracyte Inc
11/02/202514:30Business WireVeracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU SymposiumNASDAQ:VCYTVeracyte Inc
05/02/202514:30Business WireNew Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder CancerNASDAQ:VCYTVeracyte Inc
04/02/202522:30Business WireVeracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025NASDAQ:VCYTVeracyte Inc
05/12/202422:05Business WireVeracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesNASDAQ:VCYTVeracyte Inc
12/11/202415:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VCYTVeracyte Inc
07/11/202414:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCYTVeracyte Inc
06/11/202422:05Business WireVeracyte Announces Third Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
17/10/202400:43Business WireVeracyte to Release Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:VCYTVeracyte Inc
02/10/202414:20Business WireNew Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American MenNASDAQ:VCYTVeracyte Inc
15/09/202414:45Business WireNew Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate CancerNASDAQ:VCYTVeracyte Inc
04/09/202422:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
04/09/202422:05Business WireVeracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of DirectorsNASDAQ:VCYTVeracyte Inc
26/08/202423:30Business WireVeracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:VCYTVeracyte Inc
26/08/202415:00Business WireVeracyte Named a Greater Bay Area Top Workplace by the San Francisco ChronicleNASDAQ:VCYTVeracyte Inc
06/08/202422:05Business WireVeracyte Announces Second Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
17/07/202423:00Business WireVeracyte to Release Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:VCYTVeracyte Inc
12/06/202422:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCYTVeracyte Inc
03/06/202422:05Business WireVeracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid TumorsNASDAQ:VCYTVeracyte Inc
22/05/202422:05Business WireVeracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and CancerNASDAQ:VCYTVeracyte Inc
07/05/202422:05Business WireVeracyte Announces First Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
06/05/202422:05Business Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingNASDAQ:VCYTVeracyte Inc
22/04/202423:00Business WireVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:VCYTVeracyte Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VCYT

La tua Cronologia

NYSE
BCO
Brinks
NYSE
JNJ
Johnson and Johnson
NYSE
ALL
Allstate
LBNK
COCOUSDT
0xCoco
AMEX
PZA
Invesco National AMTFree...
AMEX
FXE
Invesco CurrencyShares E...
NYSE
HCA
HCA Healthcare
EU
ORABV
Orange SA 1.5% 09sep2027
EU
BP33P
Banque Postalela null
EU
BP17P
Banque Postalela null
AMEX
XBI
SPDR S&P Biotech
NYSE
WGO
Winnebago Industries
NYSE
NVO
Novo Nordisk
BOV
TECK11
Teck Resources
AMEX
MVV
ProShares Ultra MidCap400
AMEX
PSI
Invesco Semiconductors ETF
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci